Global Endocrine Therapy Drugs (ETDs) Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Endocrine Therapy Drugs (ETDs) will have significant change from previous year. By the most conservative estimates of global Endocrine Therapy Drugs (ETDs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Endocrine Therapy Drugs (ETDs) market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Endocrine Therapy Drugs (ETDs) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Endocrine Therapy Drugs (ETDs), covering the supply chain analysis, impact assessment to the Endocrine Therapy Drugs (ETDs) market size growth rate in several scenarios, and the measures to be undertaken by Endocrine Therapy Drugs (ETDs) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Antidiabetic Drugs
Anti-osteoporosis Drugs
Contraceptive
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Diabetes Treatment
Osteoporosis Treatment
Contraception
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
AstraZeneca
Sanofi
MSD
Generex Biotechnology
Bayer
Pfizer
Tonghua Dongbao Pharmaceutical
Huadong Medicine
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Endocrine Therapy Drugs (ETDs) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Endocrine Therapy Drugs (ETDs) market by identifying its various subsegments.
Focuses on the key global Endocrine Therapy Drugs (ETDs) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Endocrine Therapy Drugs (ETDs) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Endocrine Therapy Drugs (ETDs) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Endocrine Therapy Drugs (ETDs)?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Endocrine Therapy Drugs (ETDs) Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endocrine Therapy Drugs (ETDs) Consumption 2015-2025
2.1.2 Endocrine Therapy Drugs (ETDs) Consumption CAGR by Region
2.2 Endocrine Therapy Drugs (ETDs) Segment by Type
2.2.1 Antidiabetic Drugs
2.2.2 Anti-osteoporosis Drugs
2.2.3 Contraceptive
2.2.4 Other
2.3 Endocrine Therapy Drugs (ETDs) Consumption by Type
2.3.1 Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
2.3.2 Global Endocrine Therapy Drugs (ETDs) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Endocrine Therapy Drugs (ETDs) Sale Price by Type (2015-2020)
2.4 Endocrine Therapy Drugs (ETDs) Segment by Application
2.4.1 Diabetes Treatment
2.4.2 Osteoporosis Treatment
2.4.3 Contraception
2.4.4 Other
2.5 Endocrine Therapy Drugs (ETDs) Consumption by Application
2.5.1 Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
2.5.2 Global Endocrine Therapy Drugs (ETDs) Value and Market Share by Type (2015-2020)
2.5.3 Global Endocrine Therapy Drugs (ETDs) Sale Price by Type (2015-2020)
3 Global Endocrine Therapy Drugs (ETDs) by Company
3.1 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Company
3.1.1 Global Endocrine Therapy Drugs (ETDs) Sales by Company (2018-2020)
3.1.2 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Company (2018-2020)
3.2 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company
3.2.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Company (2018-2020)
3.2.2 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company (2018-2020)
3.3 Global Endocrine Therapy Drugs (ETDs) Sale Price by Company
3.4 Global Endocrine Therapy Drugs (ETDs) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Endocrine Therapy Drugs (ETDs) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Endocrine Therapy Drugs (ETDs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Endocrine Therapy Drugs (ETDs) by Regions
4.1 Endocrine Therapy Drugs (ETDs) by Regions
4.2 Americas Endocrine Therapy Drugs (ETDs) Consumption Growth
4.3 APAC Endocrine Therapy Drugs (ETDs) Consumption Growth
4.4 Europe Endocrine Therapy Drugs (ETDs) Consumption Growth
4.5 Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Growth
5 Americas
5.1 Americas Endocrine Therapy Drugs (ETDs) Consumption by Countries
5.1.1 Americas Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020)
5.1.2 Americas Endocrine Therapy Drugs (ETDs) Value by Countries (2015-2020)
5.2 Americas Endocrine Therapy Drugs (ETDs) Consumption by Type
5.3 Americas Endocrine Therapy Drugs (ETDs) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Endocrine Therapy Drugs (ETDs) Consumption by Regions
6.1.1 APAC Endocrine Therapy Drugs (ETDs) Consumption by Regions (2015-2020)
6.1.2 APAC Endocrine Therapy Drugs (ETDs) Value by Regions (2015-2020)
6.2 APAC Endocrine Therapy Drugs (ETDs) Consumption by Type
6.3 APAC Endocrine Therapy Drugs (ETDs) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Endocrine Therapy Drugs (ETDs) by Countries
7.1.1 Europe Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020)
7.1.2 Europe Endocrine Therapy Drugs (ETDs) Value by Countries (2015-2020)
7.2 Europe Endocrine Therapy Drugs (ETDs) Consumption by Type
7.3 Europe Endocrine Therapy Drugs (ETDs) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Endocrine Therapy Drugs (ETDs) by Countries
8.1.1 Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Endocrine Therapy Drugs (ETDs) Value by Countries (2015-2020)
8.2 Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption by Type
8.3 Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Endocrine Therapy Drugs (ETDs) Distributors
10.3 Endocrine Therapy Drugs (ETDs) Customer
11 Global Endocrine Therapy Drugs (ETDs) Market Forecast
11.1 Global Endocrine Therapy Drugs (ETDs) Consumption Forecast (2021-2025)
11.2 Global Endocrine Therapy Drugs (ETDs) Forecast by Regions
11.2.1 Global Endocrine Therapy Drugs (ETDs) Forecast by Regions (2021-2025)
11.2.2 Global Endocrine Therapy Drugs (ETDs) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Endocrine Therapy Drugs (ETDs) Forecast by Type
11.8 Global Endocrine Therapy Drugs (ETDs) Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Information
12.1.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.1.3 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk Latest Developments
12.2 AstraZeneca
12.2.1 Company Information
12.2.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.2.3 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Sanofi
12.3.1 Company Information
12.3.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.3.3 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 MSD
12.4.1 Company Information
12.4.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.4.3 MSD Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 MSD Latest Developments
12.5 Generex Biotechnology
12.5.1 Company Information
12.5.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.5.3 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Generex Biotechnology Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.6.3 Bayer Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Pfizer
12.7.1 Company Information
12.7.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.7.3 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 Tonghua Dongbao Pharmaceutical
12.8.1 Company Information
12.8.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.8.3 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Tonghua Dongbao Pharmaceutical Latest Developments
12.9 Huadong Medicine
12.9.1 Company Information
12.9.2 Endocrine Therapy Drugs (ETDs) Product Offered
12.9.3 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Huadong Medicine Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Endocrine Therapy Drugs (ETDs) Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Endocrine Therapy Drugs (ETDs) Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Endocrine Therapy Drugs (ETDs) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Antidiabetic Drugs
Table 7. Major Players of Anti-osteoporosis Drugs
Table 8. Major Players of Contraceptive
Table 9. Major Players of Other
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
Table 12. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2015-2020) ($ million)
Table 13. Global Endocrine Therapy Drugs (ETDs) Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Endocrine Therapy Drugs (ETDs) Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application (2015-2020)
Table 17. Global Endocrine Therapy Drugs (ETDs) Value by Application (2015-2020)
Table 18. Global Endocrine Therapy Drugs (ETDs) Value Market Share by Application (2015-2020)
Table 19. Global Endocrine Therapy Drugs (ETDs) Sale Price by Application (2015-2020)
Table 20. Global Endocrine Therapy Drugs (ETDs) Sales by Company (2017-2019) (Kiloton)
Table 21. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Company (2017-2019)
Table 22. Global Endocrine Therapy Drugs (ETDs) Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company (2017-2019)
Table 24. Global Endocrine Therapy Drugs (ETDs) Sale Price by Company (2017-2019)
Table 25. Global Endocrine Therapy Drugs (ETDs) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Endocrine Therapy Drugs (ETDs) Products Offered
Table 27. Endocrine Therapy Drugs (ETDs) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Endocrine Therapy Drugs (ETDs) Consumption by Regions 2015-2020 (Kiloton)
Table 29. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Regions 2015-2020
Table 30. Global Endocrine Therapy Drugs (ETDs) Value by Regions 2015-2020 ($ Millions)
Table 31. Global Endocrine Therapy Drugs (ETDs) Value Market Share by Regions 2015-2020
Table 32. Americas Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020) (Kiloton)
Table 33. Americas Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries (2015-2020)
Table 34. Americas Endocrine Therapy Drugs (ETDs) Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Endocrine Therapy Drugs (ETDs) Value Market Share by Countries (2015-2020)
Table 36. Americas Endocrine Therapy Drugs (ETDs) Consumption by Type (2015-2020) (Kiloton)
Table 37. Americas Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
Table 38. Americas Endocrine Therapy Drugs (ETDs) Consumption by Application (2015-2020) (Kiloton)
Table 39. Americas Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application (2015-2020)
Table 40. APAC Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020) (Kiloton)
Table 41. APAC Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries (2015-2020)
Table 42. APAC Endocrine Therapy Drugs (ETDs) Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Endocrine Therapy Drugs (ETDs) Value Market Share by Regions (2015-2020)
Table 44. APAC Endocrine Therapy Drugs (ETDs) Consumption by Type (2015-2020) (Kiloton)
Table 45. APAC Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
Table 46. APAC Endocrine Therapy Drugs (ETDs) Consumption by Application (2015-2020) (Kiloton)
Table 47. APAC Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application (2015-2020)
Table 48. Europe Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020) (Kiloton)
Table 49. Europe Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries (2015-2020)
Table 50. Europe Endocrine Therapy Drugs (ETDs) Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Endocrine Therapy Drugs (ETDs) Value Market Share by Countries (2015-2020)
Table 52. Europe Endocrine Therapy Drugs (ETDs) Consumption by Type (2015-2020) (Kiloton)
Table 53. Europe Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
Table 54. Europe Endocrine Therapy Drugs (ETDs) Consumption by Application (2015-2020) (Kiloton)
Table 55. Europe Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption by Countries (2015-2020) (Kiloton)
Table 57. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Endocrine Therapy Drugs (ETDs) Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Endocrine Therapy Drugs (ETDs) Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption by Type (2015-2020) (Kiloton)
Table 61. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption by Application (2015-2020) (Kiloton)
Table 63. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application (2015-2020)
Table 64. Endocrine Therapy Drugs (ETDs) Distributors List
Table 65. Endocrine Therapy Drugs (ETDs) Customer List
Table 66. Global Endocrine Therapy Drugs (ETDs) Consumption Forecast by Countries (2021-2025) (Kiloton)
Table 67. Global Endocrine Therapy Drugs (ETDs) Consumption Market Forecast by Regions
Table 68. Global Endocrine Therapy Drugs (ETDs) Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Endocrine Therapy Drugs (ETDs) Value Market Share Forecast by Regions
Table 70. Global Endocrine Therapy Drugs (ETDs) Consumption Forecast by Type (2021-2025) (Kiloton)
Table 71. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Endocrine Therapy Drugs (ETDs) Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Endocrine Therapy Drugs (ETDs) Value Market Share Forecast by Type (2021-2025)
Table 74. Global Endocrine Therapy Drugs (ETDs) Consumption Forecast by Application (2021-2025) (Kiloton)
Table 75. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Endocrine Therapy Drugs (ETDs) Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Endocrine Therapy Drugs (ETDs) Value Market Share Forecast by Application (2021-2025)
Table 78. Novo Nordisk Product Offered
Table 79. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 80. Novo Nordisk Main Business
Table 81. Novo Nordisk Latest Developments
Table 82. Novo Nordisk Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 83. AstraZeneca Product Offered
Table 84. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. AstraZeneca Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Product Offered
Table 89. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. Sanofi Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 93. MSD Product Offered
Table 94. MSD Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 95. MSD Main Business
Table 96. MSD Latest Developments
Table 97. MSD Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 98. Generex Biotechnology Product Offered
Table 99. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 100. Generex Biotechnology Main Business
Table 101. Generex Biotechnology Latest Developments
Table 102. Generex Biotechnology Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer Product Offered
Table 104. Bayer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 105. Bayer Main Business
Table 106. Bayer Latest Developments
Table 107. Bayer Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Product Offered
Table 109. Pfizer Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 113. Tonghua Dongbao Pharmaceutical Product Offered
Table 114. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 115. Tonghua Dongbao Pharmaceutical Main Business
Table 116. Tonghua Dongbao Pharmaceutical Latest Developments
Table 117. Tonghua Dongbao Pharmaceutical Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
Table 118. Huadong Medicine Product Offered
Table 119. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2020E)
Table 120. Huadong Medicine Main Business
Table 121. Huadong Medicine Latest Developments
Table 122. Huadong Medicine Basic Information, Company Total Revenue (in $ million), Endocrine Therapy Drugs (ETDs) Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Endocrine Therapy Drugs (ETDs)
Figure 2. Endocrine Therapy Drugs (ETDs) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Endocrine Therapy Drugs (ETDs) Consumption Growth Rate 2015-2025 (Kiloton)
Figure 5. Global Endocrine Therapy Drugs (ETDs) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Antidiabetic Drugs
Figure 7. Product Picture of Anti-osteoporosis Drugs
Figure 8. Product Picture of Contraceptive
Figure 9. Product Picture of Other
Figure 10. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type (2015-2020)
Figure 11. Global Endocrine Therapy Drugs (ETDs) Value Market Share by Type (2015-2020)
Figure 12. Endocrine Therapy Drugs (ETDs) Consumed in Diabetes Treatment
Figure 13. Global Endocrine Therapy Drugs (ETDs) Market: Diabetes Treatment (2015-2020) (Kiloton)
Figure 14. Global Endocrine Therapy Drugs (ETDs) Market: Diabetes Treatment (2015-2020) ($ Millions)
Figure 15. Endocrine Therapy Drugs (ETDs) Consumed in Osteoporosis Treatment
Figure 16. Global Endocrine Therapy Drugs (ETDs) Market: Osteoporosis Treatment (2015-2020) (Kiloton)
Figure 17. Global Endocrine Therapy Drugs (ETDs) Market: Osteoporosis Treatment (2015-2020) ($ Millions)
Figure 18. Endocrine Therapy Drugs (ETDs) Consumed in Contraception
Figure 19. Global Endocrine Therapy Drugs (ETDs) Market: Contraception (2015-2020) (Kiloton)
Figure 20. Global Endocrine Therapy Drugs (ETDs) Market: Contraception (2015-2020) ($ Millions)
Figure 21. Endocrine Therapy Drugs (ETDs) Consumed in Other
Figure 22. Global Endocrine Therapy Drugs (ETDs) Market: Other (2015-2020) (Kiloton)
Figure 23. Global Endocrine Therapy Drugs (ETDs) Market: Other (2015-2020) ($ Millions)
Figure 24. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application (2015-2020)
Figure 25. Global Endocrine Therapy Drugs (ETDs) Value Market Share by Application (2015-2020)
Figure 26. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Company in 2017
Figure 27. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Company in 2019
Figure 28. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company in 2017
Figure 29. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company in 2019
Figure 30. Global Endocrine Therapy Drugs (ETDs) Sale Price by Company in 2019
Figure 31. Global Endocrine Therapy Drugs (ETDs) Consumption Market Share by Regions 2015-2020
Figure 32. Global Endocrine Therapy Drugs (ETDs) Value Market Share by Regions 2015-2020
Figure 33. Americas Endocrine Therapy Drugs (ETDs) Consumption 2015-2020 (Kiloton)
Figure 34. Americas Endocrine Therapy Drugs (ETDs) Value 2015-2020 ($ Millions)
Figure 35. APAC Endocrine Therapy Drugs (ETDs) Consumption 2015-2020 (Kiloton)
Figure 36. APAC Endocrine Therapy Drugs (ETDs) Value 2015-2020 ($ Millions)
Figure 37. Europe Endocrine Therapy Drugs (ETDs) Consumption 2015-2020 (Kiloton)
Figure 38. Europe Endocrine Therapy Drugs (ETDs) Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption 2015-2020 (Kiloton)
Figure 40. Middle East & Africa Endocrine Therapy Drugs (ETDs) Value 2015-2020 ($ Millions)
Figure 41. Americas Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries in 2019
Figure 42. Americas Endocrine Therapy Drugs (ETDs) Value Market Share by Countries in 2019
Figure 43. Americas Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type in 2019
Figure 44. Americas Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application in 2019
Figure 45. United States Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 46. United States Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 48. Canada Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 50. Mexico Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries in 2019
Figure 52. APAC Endocrine Therapy Drugs (ETDs) Value Market Share by Regions in 2019
Figure 53. APAC Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type in 2019
Figure 54. APAC Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application in 2019
Figure 55. China Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 56. China Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 58. Japan Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 60. Korea Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 62. Southeast Asia Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 63. India Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 64. India Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 66. Australia Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries in 2019
Figure 68. Europe Endocrine Therapy Drugs (ETDs) Value Market Share by Countries in 2019
Figure 69. Europe Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type in 2019
Figure 70. Europe Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application in 2019
Figure 71. Germany Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 72. Germany Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 73. France Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 74. France Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 75. UK Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 76. UK Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 78. Italy Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 80. Russia Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Endocrine Therapy Drugs (ETDs) Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption Market Share by Application in 2019
Figure 85. Egypt Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 86. Egypt Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 88. South Africa Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 90. Israel Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 92. Turkey Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Endocrine Therapy Drugs (ETDs) Consumption Growth 2015-2020 (Kiloton)
Figure 94. GCC Countries Endocrine Therapy Drugs (ETDs) Value Growth 2015-2020 ($ Millions)
Figure 95. Global Endocrine Therapy Drugs (ETDs) Consumption Growth Rate Forecast (2021-2025) (Kiloton)
Figure 96. Global Endocrine Therapy Drugs (ETDs) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 98. Americas Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 99. APAC Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 100. APAC Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 101. Europe Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 102. Europe Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 104. Middle East & Africa Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 105. United States Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 106. United States Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 107. Canada Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 108. Canada Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 109. Mexico Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 110. Mexico Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 111. Brazil Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 112. Brazil Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 113. China Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 114. China Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 115. Japan Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 116. Japan Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 117. Korea Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 118. Korea Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 120. Southeast Asia Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 121. India Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 122. India Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 123. Australia Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 124. Australia Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 125. Germany Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 126. Germany Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 127. France Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 128. France Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 129. UK Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 130. UK Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 131. Italy Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 132. Italy Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 133. Russia Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 134. Russia Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 135. Spain Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 136. Spain Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 137. Egypt Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 138. Egypt Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 139. South Africa Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 140. South Africa Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 141. Israel Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 142. Israel Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 143. Turkey Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 144. Turkey Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Endocrine Therapy Drugs (ETDs) Consumption 2021-2025 (Kiloton)
Figure 146. GCC Countries Endocrine Therapy Drugs (ETDs) Value 2021-2025 ($ Millions)
Figure 147. Novo Nordisk Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 148. AstraZeneca Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 149. Sanofi Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 150. MSD Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 151. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 152. Bayer Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 153. Pfizer Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 154. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Figure 155. Huadong Medicine Endocrine Therapy Drugs (ETDs) Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets